s6y

COSCIENS Biopharma Inc.

Ticker
CSCIF
CIK
1113423
Industry
Perfumes, Cosmetics & Other Toilet Preparations
Formerly
Aeterna Zentaris Inc., AETERNA LABORATORIES INC

Ownership 63

  1. SC 13E3/A Schedule filed to report going private transactions
  2. SC 13E3/A Schedule filed to report going private transactions
  3. SC 13E3/A Schedule filed to report going private transactions
  4. SC 13E3/A Schedule filed to report going private transactions
  5. SC 13E3/A Schedule filed to report going private transactions
  6. SC 13E3/A Schedule filed to report going private transactions
  7. SC 13E3/A Schedule filed to report going private transactions
  8. SC 13E3 Schedule filed to report going private transactions
  9. SC 13D Major Shareholders
  10. SC 13G Major Shareholders

All 63 ownership filings

Prospectus 37

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses

All 37 prospectus filings

Other 817

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. SCHEDULE 13D/A

All 817 other filings